MedPath

Prospective Regional Epilepsy Database

Recruiting
Conditions
Epilepsy
Interventions
Other: Seizure status
Diagnostic Test: Tests
Other: Epilepsy
Other: Demographics and psychosocial
Other: Health care
Registration Number
NCT04559919
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Brief Summary

PREDICT is an observational study following adults with an unprovoked seizure or epilepsy in the health care region of western Sweden. The objective is to identify biomarkers and/or genetic predisposition of relevance for diagnosis and/or treatment of epilepsy and study the long-term prognosis and consequences of epilepsy.

Detailed Description

Adults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in the health care region of western Sweden (VGR) at the time of inclusion.

Baseline data and outcome variables are collected from several patient registries: the electronic medical records system in the health care region VGR and Swedish National Registers of healthcare, income, and employment managed by The National Board of Health and Welfare or Statistics Sweden, both of which are government agencies.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Over 18 years of age
  • An unprovoked seizure within the last year or a diagnosis of epilepsy according to the current International League Against Epilepsy definition (epilepsy with seizure in the last ten or antiepileptic drug treatment in the last five years)
Exclusion Criteria
  • Expected survival less than two years
  • Inability to give informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adults with epilepsySeizure statusAdults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in VGR at the time of inclusion. Languages available: Swedish, English, Arabic. Based on the clinical information, patients can be categorized into relevant groups; single seizure, seizure-free with epilepsy, and drug-resistant epilepsy. Subgroups may also be selected based on age, sex, epilepsy sub-diagnosis, cause of epilepsy, use of a particular antiepileptic drug, or experience of a particular side effect.
Adults with epilepsyTestsAdults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in VGR at the time of inclusion. Languages available: Swedish, English, Arabic. Based on the clinical information, patients can be categorized into relevant groups; single seizure, seizure-free with epilepsy, and drug-resistant epilepsy. Subgroups may also be selected based on age, sex, epilepsy sub-diagnosis, cause of epilepsy, use of a particular antiepileptic drug, or experience of a particular side effect.
Adults with epilepsyEpilepsyAdults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in VGR at the time of inclusion. Languages available: Swedish, English, Arabic. Based on the clinical information, patients can be categorized into relevant groups; single seizure, seizure-free with epilepsy, and drug-resistant epilepsy. Subgroups may also be selected based on age, sex, epilepsy sub-diagnosis, cause of epilepsy, use of a particular antiepileptic drug, or experience of a particular side effect.
Adults with epilepsyDemographics and psychosocialAdults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in VGR at the time of inclusion. Languages available: Swedish, English, Arabic. Based on the clinical information, patients can be categorized into relevant groups; single seizure, seizure-free with epilepsy, and drug-resistant epilepsy. Subgroups may also be selected based on age, sex, epilepsy sub-diagnosis, cause of epilepsy, use of a particular antiepileptic drug, or experience of a particular side effect.
Adults with epilepsyHealth careAdults over 18 years of age, with an unprovoked seizure in the last year or epilepsy, resident in VGR at the time of inclusion. Languages available: Swedish, English, Arabic. Based on the clinical information, patients can be categorized into relevant groups; single seizure, seizure-free with epilepsy, and drug-resistant epilepsy. Subgroups may also be selected based on age, sex, epilepsy sub-diagnosis, cause of epilepsy, use of a particular antiepileptic drug, or experience of a particular side effect.
Primary Outcome Measures
NameTimeMethod
epilepsybaseline and years 1,2,3,4,5,6,7,8,9,10

more than one seizure after first seizure

seizure statusbaseline and years 1,2,3,4,5,6,7,8,9,10

the number of seizures in last two months and overall

drug resistant epilepsybaseline and years 1,2,3,4,5,6,7,8,9,10

epilepsy that has not responded to two antiepileptic drugs

severe side effects of antiepileptic drugbaseline and years 1,2,3,4,5,6,7,8,9,10
psychosocial outcomesbaseline and years 1,2,3,4,5,6,7,8,9,10

employment, marital status, income, sick leave

Secondary Outcome Measures
NameTimeMethod
received health carebaseline and years 1,2,3,4,5,6,7,8,9,10

the number of visits for epilepsy, missed appointments, time intervals between visits

Trial Locations

Locations (3)

Södra Älvsborgs Sjukhus

🇸🇪

Borås, Sweden

Sahlgrenska University Hospital

🇸🇪

Gothenburg, Sweden

Sjukhusen i Väster

🇸🇪

Gothenburg, Sweden

© Copyright 2025. All Rights Reserved by MedPath